Microarray analysis of insulin-regulated gene expression in the liver: The use of transgenic mice co-expressing insulin-siRNA and human IDE as an animal model

International Journal of Molecular Medicine

Volumn 20, Issue 6, 2007, Pages 829-835

  Jee, Seungwan ^a   Hwang, Daeyoun ^a   Seo, Sujin ^a   Kim, Yongkyu ^a   Kim, Chuelkyu ^a   Kim, Byungguk ^a   Shim, Sunbo ^a   Lee, Suhae ^a   Sin, Jisoon ^a   Bae, Changjun ^a   Lee, Byoungchun ^a   Jang, Meekyung ^a   Kim, Minsun ^a   Yim, Suyoun ^a   Jang, Insurk ^b   Cho, Jungsik ^a   Chae, Kabryong ^a  

^a CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^b Gyeongsang National University   (South Korea)

Author keywords

Diabetes model; IDE; Insulin; Microarray; siRNA

Indexed keywords

INSULIN; INSULINASE; SMALL INTERFERING RNA;

ANIMAL; ARTICLE; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; HUMAN; LIVER; METABOLISM; MOLECULAR GENETICS; MOUSE; PHYSIOLOGY; TRANSGENIC MOUSE;

ANIMALS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INSULIN; INSULYSIN; LIVER; MICE; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA, SMALL INTERFERING;

EID: 42149146205     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.20.6.829     Document Type: Article

References (42)

1. Mittelman SD, Fu YY, Rebrin K, Steil G and Bergman RN: Indirect effect of insulin to suppress endogenous glucose production is dominant, even with hyperglucagonemia. J Clin Invest 100: 3121-3130, 1997.
2. Giacca A, Fisher SJ, Shi ZQ, Gupta R, Lickley HL and Vranic M: Importance of peripheral insulin levels for insulin-induced suppression of glucose production in depancreatized dogs. J Clin Invest 90: 1769-1777, 1992.
3. Lewis GF, Zinman B, Groenewoud Y, Vranic M and Giacca A: Hepatic glucose production is regulated both by direct hepatic and extrahepatic effects of insulin in humans. Diabetes 45: 454-462, 1996. (Pubitemid 26110251)
4. Lewis GF, Carpentier A, Vranic M and Giacca A: Resistance to insulin's acute direct hepatic effect in suppressing steady-state glucose production in individuals with type 2 diabetes. Diabetes 48: 570-576, 1999.
5. Ferrannini E, Galvan AQ, Gastaldelli A, Camastra S, Sironi AM, Toschi E, Baldi S, Frascerra S, Monzani F, Antonelli A, Nannipieri M, Mari A, Seghieri G and Natali A: Insulin: new roles for an ancient hormone. Eur J Clin Invest 29: 842-852, 1999.
6. Gastaldelli A, Toschi E, Pwttiti M, Frascerra S, Quinones-galvan A, Sironi AM, Natali A and Ferrannini E: Effect of physiological hyperinsulinemia on gluconeogenesis in nondiabetic subjects and in type 2 diabetic patients. Diabetes 50: 1807-1812, 2001.
7. Boden G, Chen X, Ruiz J, White JV and Rossetti L: Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93: 2438-2446, 1994.
8. Duonf DT, Waltner-Law ME, Sears R, Sealy L and Granner DK: Insulin inhibits hepatocellular glucose production by utilizing liver-enriched transcriptional inhibitory protein to disrupt the association of CREB-binding protein and RNA polymerase II with the phosphoenolpyruvate carboxykinase gene promoter. J Biol Chem 30: 32234-32242, 2002.
9. Hall RK, Yamasaki T, Kucera T, Waltner-Law ME, O'Brien R and Granner DK: Regulation of phosphoenolpyruvate carboxykinase and insulin-like growth factor-binding protein-1 gene expression by insulin. The role of winged helix/forkhead proteins. J Biol Chem 275: 30169-30175, 2000.
10. O'Brien RM and Granner DK: Regulation of gene expression by insulin. Physiol Rev 76: 1109-1161, 1996.
11. Sindelar DK, Chu CA, Neal DW and Cherrington AD: Interaction of equal increments in arterial and portal vein insulin on hepatic glucose production in the dog. Am J Physiol 273: E972-E980, 1997.
12. Lewis GF, Vranic M and Giacca A: Role of free fatty acids and glucagon in the peripheral effect of insulin on glucose production in humans. Am J Physiol 275: E177-E186, 1998.
13. Obici S, Zhang BB, Karkanias G and Rossetti L: Hypothalamic insulin signaling is required for inhibition of glucose production. Nat Med 8: 1376-1382, 2002. (Pubitemid 36019422)
14. Hwang DY, Oh JH, Kim YK, Shim SB, Jee SW, Lee SH, Seo SJ, Song YS, Nam KT, Cho JY, Hwang J, Jang IS and Cho JS: The overexpression of insulin-siRNA and insulin degrading enzyme decrease insulin levels in vitro and in vivo. Lab Anim Res 21: 96-104, 2005.
15. Hwang DY, Seo SJ, Kim KK, Kim YK, Shim SB, Jee SW, Lee SH, Cho JY, Jang IS, Kang BC and Cho JS: The insulin level was significantly decreased in transgenic mice co-expressing the human insulin degrading enzyme and insulinsiRNA. Lab Anim Res 22: 39-47, 2006.
16. Hwang DY, Seo SJ, Kim YK, Kim KK, Shim SB, Jee SW, Lee SH, Sin JS, Cho JY, Kang BC, Jang IS and Cho JS: Significant change in insulin production, glucose tolerance and ER stress signaling in transgenic mice coexpressing insulin-siRNA and human IDE. Int J Mol Med 19: 65-73, 2007.
17. Hasuwa H, Kaseda K, Einarsdottir T and Okabe M: Small interfering RNA and gene silencing in transgenic mice and rats. FEBS Lett 532: 227-230, 2002.
18. Hannon GJ: RNA interference. Nature 418: 244-251, 2002.
19. Hutvagner G and Zamore PD: RNAi: nature abhors a doublestrand. Curr Opin Genet Dev 12: 225-232, 2002.
20. Fire A, Xu S, Montgomery MK, Kostas SA, Driver SE and Mello CC: Potent and specific genetic interference by double-strand RNA in Caenorhabditis elegans. Nature 391: 806-811, 1998. (Pubitemid 28099681)
21. Brummelkamp TR, Bernards R and Agami R: A system for stable expression of short interfering RNAs in mammalian cells. Science 296: 550-553, 2002.
22. Lee NS, Dohlima T, Bauer G, Li H, Li MJ, Ehsani A, Salvaterra P and Rossi J: Expression of small interfering RNAs targeted against HIV-1 rev transcripts in human cells. Nat Biotechnol 20: 500-505, 2002.
23. Yu JY, Deruiter SL and Turner DL: RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells. Proc Natl Acad Sci USA 99: 6047-6052, 2002.
24. Duckworth WC, Bennett RG and Hamel FG: Insulin degradation: progress and potential. Endocr Rev 19: 608-624, 1998.
25. Seta KA and Roth RA: Overexpression of insulin degrading enzyme: cellular localization and effects on insulin signaling. Biochem Biophys Res Commun 231: 167-171, 1997.
26. Vekrellis K, Ye Z, Qiu WQ, Walsh D, Hartley D, Chesneau V, Rosner MR and Selkoe DJ: Neurons regulate extracellular levels of amyloid beta-protein via proteolysis by insulin-degrading enzyme. J Neurosci 20: 1657-1665, 2000.
27. Kirschmer RJ and Goldberg AL: A high molecular weight metalloendopeptidase from the cytosol of mammalian cells. J Biol Chem 258: 967-976, 1983.
28. Muller D, Baumeister H, Buck F and Richter D: Atrial natriuretic peptide (ANP) is a high-affinity substrate for rat insulin-degrading enzyme. Eur J Biochem 202: 285-292, 1991.
29. Garcia JV, Gehm BD and Rosener MR: An evolutionarily conserved enzyme degrades transforming growth factor-alpha as well as insulin. J Cell Biol 109: 1301-1307, 1989.
30. Gehm BD and Rosner MR: Regulation of insulin, epidermal growth factor, and transforming growth factor-alpha levels by growth factor-degrading enzymes. Endocrinology 128: 1603-16010, 1991.
31. Muller D, Schulze C, Baumeister H, Buck F and Richter D: Rat insulin-degrading enzyme: cleavage pattern of the natriuretic peptide hormones ANP, BNP, and CNP revealed by HPLC and mass spectrometry. Biochemistry 31: 11138-11143, 1992.
32. Safavi A, Miller BC, Cottam L and Hersh LB: Identification of gamma-endorphin-generating enzyme as insulin-degrading enzyme. Biochemistry 35: 14318-14325, 1996.
33. Bennett RG, Duckworth WC and Hamel FG: Degradation of amylin by insulin-degrading enzyme. J Biol Chem 275: 36621-36625, 2000.
34. Mukherjee A, Song E, Kihiko-Ehmann M, Goodman JP Jr, Pyrek JS, Esyus S and Hersh LB: Insulysin hydrolyzes amyloid beta peptides to products that are neither neurotoxic nor deposit on amyloid plaques. J Neurosci 20: 8745-8749, 2000.
35. Edbauer D, Willem M, Lammich S, Steiner H and Haass C: Insulin-degrading enzyme rapidly removes the beta-amyloid precursor protein intracellular domain (AICD). J Biol Chem 277: 13389-13393, 2002. (Pubitemid 34967931)
36. Kupfer SR, Wilson EM and French FS: Androgen and glucocorticoid receptors interact with insulin degrading enzyme. J Biol Chem 269: 20622-20628, 1994.
37. Duckworth WC, Bennett RG and Hamel FG: A direct inhibitory effect of insulin on a cytosolic proteolytic complex containing insulin-degradation: progress and multicatalytic proteinase. J Biol Chem 269: 24575-24580, 1994.
38. Petrusz P, Jeyaraj DA and Grossman G: Microarray analysis of androgen-regulated gene expression in testis: the use of the androgen-binding protein (ABP)-transgenic mouse as a model. Reprod Biol Endocrinol 70: 1-14, 2005.
39. Colombo M, Kruhoeffer M, Gregersen S, Agger A, Jeppesen P, Oemtoft T and Hermansen K: Energy restriction prevents the development of type 2 diabetes in Zucker diabetic fatty rats: coordinated patterns of gene expression for energy metabolism in insulin-sensitive tissues and pancreatic islets determined by oligonucleotide microarray analysis. Metabolism 55: 43-52, 2006.
40. Wilson KH, Eckenrode SE, Li QZ, Ruan QG, Yang P, Shi JD, Davoodi-Semiromi A, McIndoe RA, Croker BP and She JX: Microarray analysis of gene expression in the kidneys of new and post-onset diabetic NOD mice. Diabetes 52: 2151-2159, 2003.
41. Sreekumar R, Halvatsiotis P, Schimke JC and Nair KS: Gene expression profile in skeletal muscle of type 2 diabetes and the effect of insulin treatment. Diabetes 51: 1913-1920, 2002.
42. Kume E, Aruga C, Ishizuka Y, Takahashi K, Miwa S, Itoh M, Fujimura H, Toriumi W, Kitamura K and Doi K: Gene expression profiling in streptozotocin treated mouse liver using DNA microarray. Exp Toxicol Pathol 56: 235-244, 2005.